Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipiodol Ultra Fluid with surgical glues in vascular embolization
NCT02625389Phase 4Completed
- Sponsor
- Guerbet
- Start
- Nov 2017
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ethiodized oil in hemangioma, hemangioendothelioma, angiosarcoma and 1 more, sponsored by Guerbet. Primary endpoint: Adverse Drug Reactions During the Embolization Procedure. Started Nov 2017; status: completed.
02
Drugs
ethiodized oil
03
Conditions
hemangiomahemangioendotheliomaangiosarcomaArteriovenous Malformation (AVM)
Beyond the preview
Go deeper on NCT02625389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02625389.